R Evers

The multidrug resistance protein family.

M. Kool, R. Evers, J. Wijnholds, 1999, Biochimica et biophysica acta.

Rifampin's Acute Inhibitory and Chronic Inductive Drug Interactions: Experimental and Model‐Based Approaches to Drug–Drug Interaction Trial Design

C Gibson, X. Chu, R. Evers, 2011, Clinical pharmacology and therapeutics.

Attenuating pregnane X receptor (PXR) activation: A molecular modelling approach

R. Evers, J. Yabut, R. Mosley, 2007, Xenobiotica; the fate of foreign compounds in biological systems.

A family of drug transporters: the multidrug resistance-associated proteins.

M. Kool, R. Evers, J. Wijnholds, 2000, Journal of the National Cancer Institute.

In Vitro Methods to Support Transporter Evaluation in Drug Discovery and Development

K. Brouwer, R. Evers, K. Hoffmaster, 2013, Clinical pharmacology and therapeutics.

Drug export activity of the human canalicular multispecific organic anion transporter in polarized kidney MDCK cells expressing cMOAT (MRP2) cDNA.

M. Kool, F. Baas, R. Evers, 1998, The Journal of clinical investigation.

Validation of a microdose probe drug cocktail for clinical drug interaction assessments for drug transporters and CYP3A

W. Zeng, R. Railkar, X. Chu, 2017, Clinical pharmacology and therapeutics.